Status:
COMPLETED
COVID-19 Related Health and Infection Control Practices Among Dentists
Lead Sponsor:
American Dental Association
Conditions:
Severe Acute Respiratory Syndrome Coronavirus 2
Eligibility:
All Genders
18+ years
Brief Summary
As dentists begin reopening their practices during a global pandemic, the risk of COVID-19 infection that dentists face in providing dental care remains unknown. Estimating the occupational risk of CO...
Eligibility Criteria
Inclusion
- Primary dental practice is in United States
- 18 years of age or older
- Dentist
Exclusion
- •Answered "no" to ADA survey sent May 2020 that read "As part of ongoing efforts to monitor the effect of COVID-19 on the dental team, the ADA is interested in collecting data related to infection rates. Would you also be willing to participate in a separate, longitudinal study that would require you to report whether you or your staff have exhibited symptoms of COVID-19, and whether you have been tested or diagnosed? The study would be anonymous and under IRB protocols."
Key Trial Info
Start Date :
June 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 8 2021
Estimated Enrollment :
2196 Patients enrolled
Trial Details
Trial ID
NCT04423770
Start Date
June 8 2020
End Date
June 8 2021
Last Update
July 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
American Dental Association
Chicago, Illinois, United States, 60611